With the pharmaceutical industry's focus on oncology and more targeted therapies, the number of highly potent active pharmaceutical ingredients (HPAPIs) in development continues to increase. as does the demand for HPAPI manufacturing capacity. As described in this technical brief, Lonza has more than 20 years experience in the manufacture and handling of HPAPIs. Our expertise, capabilities, manufacturing innovation, and integrated service options are described. To learn more, please read our technical brief.
You may also be interested in:
Antibody Drug Conjugates
Drug Substance (API/HPAPI)
API Services
View our technical brief

Download now
Latest content
Latest briefing from the Knowledge Center
Used as thumbnail for Powder to Particles podcast.
Video
Small Molecule API & HPAPI Development Capacity
This video presents Lonza's capabilities, facility locations, and timelines to assist biopharma...
Webinar (on-demand)
Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug...
The rapid development of enabled forms and formulations is crucial for tackling the challenges posed...
CHI Colmar
Presentation (on-demand)
Pioneering Capsule Innovation: Accelerating Oral and Inhalable Drug Delivery
Watch Dr. Camille Dumont and Meeta Kratz's presentation at CPHI Worldwide 2024. Explore Lonza’s...
Innovaform
R&D Blog post
Transforming drug delivery through advanced capsule innovation
Capsules represent one of the oldest pharmaceutical dosage forms, with a history dating back to...
Spray Drying - Bend
White paper
Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development
This executive summary explores a risk-based approach to process qualification, demonstrating how...
Webinar (on-demand)
Excipients for Respiratory Delivery of Biologics
Local administration of biologic Active Pharmaceutical Ingredients to the lung via inhalation has...
Christine Lebeault
Interview
Responsible Sourcing and Manufacturing: Growing Towards a Sustainable Future with Lonza
In this article Christine Lebeault, Head of Applied Sustainability, Lonza Capsules & Health...
capsules in hand
Brochure
Capsugel® in-stock vegan capsule program – EMEA
Select from a variety of vegan options to satisfy your market needs quickly. Experience the many...
Couple running with dog
Webinar (on-demand)
Unlocking Pet Joint Health with Collagen - Webinar
Walking, running, playing, jumping. In this webinar, learn how you can support active owners’...
Spray Drying Bend
White paper
From Technology Selection to Final Drug Product
Many new active pharmaceutical ingredients (APIs) suffer from poor gastro-intestinal solubility in...
dry powder inhalation image
White paper
Dry Powder Vaccines to Improve Global Access and Pandemic Response
Many vaccines require cold chain storage and distribution, limiting their accessibility in...
front of Tampa building with flags
White paper
Micro-dosing: Navigating the Path from Development to Commercialization with Powder-in-Capsule...
Microdosing, a technique involving the administration of precise, minimal drug doses, can...